Skip to main content
OIDA Image Collection
Filters:
Reset 
A screenshot of an iPad screen displaying an overview of XARTEMIS XR (oxycodone HCI and acetaminophen) extended-release tablets. The slide has a title "Immediate and extended release" at the top followed by a subtitle that reads "XARTEMIS XR delivers both immediate and extended plasma concentrations allowing for a 12-hour dosing interval". Below the title there is a line graph that shows the number of patients who have been diagnosed with the disease. The graph is divided into two sections one for the first day of treatment and the other for the second day.<br /><br />The first section of the slide has the title "Specialized drug delivery technology provides slow release of drug delivery from the stomach to the stomach providing steady and consistent absorption over an extended period of time." The second section has a description of the study design which states that the study has been successful in the treatment of the condition. The third section has an important risk information section which provides further details about the study. The background of the screen is white and there are several icons at the bottom of the page.

Description Generated using AI

A screenshot of an iPad screen displaying an overview of XARTEMIS XR (oxycodone HCI and acetaminophen) extended-release tablets. The slide has a title "Immediate and extended release" at the top followed by a subtitle that reads "XARTEMIS XR delivers both immediate and extended plasma concentrations allowing for a 12-hour dosing interval". Below the title there is a line graph that shows the number of patients who have been diagnosed with the disease. The graph is divided into two sections one for the first day of treatment and the other for the second day.

The first section of the slide has the title "Specialized drug delivery technology provides slow release of drug delivery from the stomach to the stomach providing steady and consistent absorption over an extended period of time." The second section has a description of the study design which states that the study has been successful in the treatment of the condition. The third section has an important risk information section which provides further details about the study. The background of the screen is white and there are several icons at the bottom of the page.

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"A screenshot of an iPad screen displaying an overview of XARTEMIS XR (oxycodone HCI and acetaminophen) extended-release tablets. The slide has a titl...